Cargando…

Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings

OBJECTIVE: The standard treatment for cervical cancer in developed countries includes surgery and chemoradiation, with standard of care lagging in developing countries. Even in the former case, treatment frequently yields recalcitrant tumors and women succumb to disease. Here we examine the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Mitzie-Ann, Delaney, Joe R, Patel, Chandni B, Storgard, Ryan, Stupack, Dwayne G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898046/ https://www.ncbi.nlm.nih.gov/pubmed/27330277 http://dx.doi.org/10.2147/DDDT.S102241

Ejemplares similares

A strategy to combine pathway-targeted low toxicity drugs in ovarian cancer
por: Delaney, Joe R., et al.
Publicado: (2015)

Whole Genome Pathway Analysis Identifies an Association of Cadmium Response Gene Loss with Copy Number Variation in Mutant p53 Bearing Uterine Endometrial Carcinomas
por: Delaney, Joe Ryan, et al.
Publicado: (2016)

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
por: Stupack, Dwayne G., et al.
Publicado: (2001)

Nelfinavir and Nelfinavir Analogs Block Site-2 Protease Cleavage to Inhibit Castration-Resistant Prostate Cancer
por: Guan, Min, et al.
Publicado: (2015)

Induction of Suicidal Erythrocyte Death by Nelfinavir
por: Bissinger, Rosi, et al.
Publicado: (2015)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
por: Besse, Lenka, et al.
Publicado: (2023)

Nelfinavir: An Old Ally in the COVID-19 Fight?
por: Gidari, Anna, et al.
Publicado: (2022)

Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect
por: Venkatesh, D. Nagasamy, et al.
Publicado: (2015)

Bilateral uveitis associated with concurrent administration of rifabutin and nelfinavir
por: Cheng, Wen-Hsin, et al.
Publicado: (2015)

The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir
por: Subeha, Mahbuba R., et al.
Publicado: (2020)

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
por: Erath, Alexandra, et al.
Publicado: (2020)

Tamoxifen enhances the cytotoxic effects of nelfinavir in breast cancer cells
por: Brüning, Ansgar, et al.
Publicado: (2010)

New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir
por: Antunes, Dinler A., et al.
Publicado: (2014)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
por: Resino, Salvador, et al.
Publicado: (2006)

Combining metformin and nelfinavir exhibits synergistic effects against the growth of human cervical cancer cells and xenograft in nude mice
por: Xia, Chenglai, et al.
Publicado: (2017)

Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer
por: Garcia‐Soto, Arlene E., et al.
Publicado: (2021)

Cervical cancer survival in a resource-limited setting-North Central Nigeria
por: Musa, Jonah, et al.
Publicado: (2016)

Antiretroviral Treatment in Resource-Limited Settings 2012
por: Duerr, Ann, et al.
Publicado: (2012)

Confirming Cerebral Malaria Deaths in Resource-Limited Settings
por: Laman, Moses, et al.
Publicado: (2014)

Bioinformatics mentorship in a resource limited setting
por: Jjingo, Daudi, et al.
Publicado: (2021)

Elevated ethyl methanesulfonate (EMS) in nelfinavir mesylate (Viracept(®), Roche): overview
por: Pozniak, Anton, et al.
Publicado: (2009)

Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
por: Koltai, Tomas
Publicado: (2015)

Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells
por: Soprano, Maria, et al.
Publicado: (2016)

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus
por: Yamamoto, Norio, et al.
Publicado: (2004)

Crossing the quality chasm in resource-limited settings
por: Maru, Duncan Smith-Rohrberg, et al.
Publicado: (2012)

Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells
por: Kawabata, S, et al.
Publicado: (2012)

Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus
por: Hsieh, Li-En, et al.
Publicado: (2010)

Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment
por: Ohashi, Hirofumi, et al.
Publicado: (2021)

Nelfinavir restricts A549 cell growth by inhibiting STAT3 signaling
por: He, Fangli, et al.
Publicado: (2021)

Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly
por: Li, Maggie, et al.
Publicado: (2023)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
por: Chopra, Supriya, et al.
Publicado: (2022)

Considerations for setting occupational exposure limits for novel pharmaceutical modalities
por: Graham, Jessica C., et al.
Publicado: (2020)

Treatment of Cervical Spine Fractures and Subluxations without the Use of Intraoperative Fluoroscopy in Resource-Limited Settings
por: Eyenga, Victor-Claude, et al.
Publicado: (2020)

Clinical oncology in resource-limited settings
por: Buonaguro, Franco M, et al.
Publicado: (2013)

Management of neuroblastoma in limited-resource settings
por: van Heerden, Jaques, et al.
Publicado: (2020)

Environmental Cleaning in Resource-Limited Settings
por: Apisarnthanarak, Anucha, et al.
Publicado: (2018)

Meniscus Surgery in Limited Resources Setting
por: Giarso, Peter
Publicado: (2023)

Haploinsufficiency networks identify targetable patterns of allelic deficiency in low mutation ovarian cancer
por: Delaney, Joe Ryan, et al.
Publicado: (2017)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir
por: Smith, Christiana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2h7or59s7r0e1bnvvbt6c2gu5m